ClearBridge Investments’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.23M | Buy |
67,393
+59,776
| +785% | +$2.57M | ﹤0.01% | 591 |
|
|
2026
Q1 | $280K | Sell |
7,617
-1,001
| -12% | -$47.4K | ﹤0.01% | 667 |
|
|
2025
Q4 | $438K | Sell |
8,618
-882,035
| -99% | -$45.1M | ﹤0.01% | 668 |
|
|
2025
Q3 | $49.4M | Sell |
890,653
-7,332,020
| -89% | -$429M | 0.04% | 327 |
|
|
2025
Q2 | $568M | Buy |
8,222,673
+1,588,739
| +24% | +$108M | 0.46% | 62 |
|
|
2025
Q1 | $461M | Buy |
6,633,934
+2,350,617
| +55% | +$194M | 0.4% | 72 |
|
|
2024
Q4 | $368M | Buy |
4,283,317
+1,602,549
| +60% | +$173M | 0.3% | 89 |
|
|
2024
Q3 | $319M | Buy |
2,680,768
+540,054
| +25% | +$72M | 0.25% | 98 |
|
|
2024
Q2 | $306M | Sell |
2,140,714
-86,103
| -4% | -$11.4M | 0.25% | 101 |
|
|
2024
Q1 | $286M | Sell |
2,226,817
-87,444
| -4% | -$10.4M | 0.23% | 111 |
|
|
2023
Q4 | $239M | Buy |
2,314,261
+89,152
| +4% | +$8.82M | 0.21% | 122 |
|
|
2023
Q3 | $202M | Sell |
2,225,109
-409,987
| -16% | -$36.1M | 0.19% | 125 |
|
|
2023
Q2 | $213M | Sell |
2,635,096
-168,482
| -6% | -$13.8M | 0.19% | 127 |
|
|
2023
Q1 | $223M | Sell |
2,803,578
-50,054
| -2% | -$3.55M | 0.21% | 121 |
|
|
2022
Q4 | $193M | Buy |
2,853,632
+887,218
| +45% | +$52M | 0.19% | 126 |
|
|
2022
Q3 | $98M | Buy |
1,966,414
+133,954
| +7% | +$7.18M | 0.1% | 198 |
|
|
2022
Q2 | $102M | Sell |
1,832,460
-673,756
| -27% | -$37.4M | 0.1% | 198 |
|
|
2022
Q1 | $139M | Sell |
2,506,216
-2,770,316
| -53% | -$142M | 0.1% | 190 |
|
|
2021
Q4 | $295M | Sell |
5,276,532
-213,480
| -4% | -$11.6M | 0.2% | 112 |
|
|
2021
Q3 | $264M | Buy |
5,490,012
+161,120
| +3% | +$7.79M | 0.19% | 118 |
|
|
2021
Q2 | $223M | Buy |
5,328,892
+104,194
| +2% | +$4.04M | 0.16% | 146 |
|
|
2021
Q1 | $176M | Buy |
5,224,698
+170,866
| +3% | +$6.09M | 0.13% | 153 |
|
|
2020
Q4 | $177M | Buy |
5,053,832
+327,496
| +7% | +$11.3M | 0.14% | 145 |
|
|
2020
Q3 | $164M | Buy |
4,726,336
+106,218
| +2% | +$3.54M | 0.14% | 139 |
|
|
2020
Q2 | $151M | Buy |
4,620,118
+294,850
| +7% | +$9.41M | 0.14% | 142 |
|
|
2020
Q1 | $130M | Buy |
4,325,268
+293,828
| +7% | +$8.75M | 0.14% | 143 |
|
|
2019
Q4 | $118M | Buy |
4,031,440
+421,378
| +12% | +$11.7M | 0.1% | 182 |
|
|
2019
Q3 | $93.3M | Buy |
3,610,062
+655,672
| +22% | +$16.6M | 0.08% | 206 |
|
|
2019
Q2 | $75.4M | Buy |
2,954,390
+632,506
| +27% | +$15.6M | 0.07% | 237 |
|
|
2019
Q1 | $60.7M | Buy |
2,321,884
+689,978
| +42% | +$17M | 0.05% | 276 |
|
|
2018
Q4 | $37.6M | Buy |
1,631,906
+342,792
| +27% | +$7.62M | 0.04% | 337 |
|
|
2018
Q3 | $30.4M | Buy |
1,289,114
+410,652
| +47% | +$10M | 0.03% | 392 |
|
|
2018
Q2 | $20.3M | Buy |
878,462
+129,896
| +17% | +$3.09M | 0.02% | 412 |
|
|
2018
Q1 | $18.4M | Sell |
748,566
-210,952
| -22% | -$5.54M | 0.02% | 412 |
|
|
2017
Q4 | $25.7M | Buy |
959,518
+59,220
| +7% | +$1.51M | 0.02% | 393 |
|
|
2017
Q3 | $21.7M | Buy |
900,298
+56,256
| +7% | +$1.27M | 0.02% | 415 |
|
|
2017
Q2 | $18.1M | Buy |
844,042
+38,736
| +5% | +$782K | 0.02% | 438 |
|
|
2017
Q1 | $13.8M | Buy |
805,306
+58,266
| +8% | +$1.01M | 0.01% | 463 |
|
|
2016
Q4 | $13.4M | Sell |
747,040
-15,900
| -2% | -$288K | 0.01% | 451 |
|
|
2016
Q3 | $15.9M | Sell |
762,940
-434
| -0.1% | -$10.8K | 0.02% | 437 |
|
|
2016
Q2 | $20.5M | Sell |
763,374
-36,476
| -5% | -$1M | 0.02% | 405 |
|
|
2016
Q1 | $21.7M | Sell |
799,850
-97,396
| -11% | -$2.61M | 0.03% | 395 |
|
|
2015
Q4 | $26.1M | Buy |
897,246
+30,274
| +3% | +$838K | 0.03% | 378 |
|
|
2015
Q3 | $23.5M | Sell |
866,972
-62,246
| -7% | -$1.76M | 0.03% | 386 |
|
|
2015
Q2 | $25.4M | Buy |
929,218
+4,726
| +0.5% | +$133K | 0.03% | 401 |
|
|
2015
Q1 | $24.7M | Buy |
924,492
+10,192
| +1% | +$235K | 0.03% | 405 |
|
|
2014
Q4 | $19.3M | Sell |
914,300
-860
| -0.1% | -$19.2K | 0.02% | 445 |
|
|
2014
Q3 | $21.8M | Sell |
915,160
-766
| -0.1% | -$17.6K | 0.02% | 429 |
|
|
2014
Q2 | $21.2M | Sell |
915,926
-4,862
| -0.5% | -$107K | 0.02% | 439 |
|
|
2014
Q1 | $21M | Buy |
920,788
+2,548
| +0.3% | +$54.3K | 0.02% | 436 |
|
|
2013
Q4 | $17M | Buy |
918,240
+189,890
| +26% | +$3.31M | 0.02% | 442 |
|
|
2013
Q3 | $12.3M | Sell |
728,350
-24,780
| -3% | -$417K | 0.02% | 468 |
|
|
2013
Q2 | $11.7M | Buy |
+753,130
| New | +$12.5M | 0.02% | 456 |
|
Other funds holding NVO
F
EHC
ClearBridge Investments's NVO Position: Q2 2026 in Review
ClearBridge Investments increased its Novo Nordisk (NVO) stake by 785% in Q2 2026, buying an estimated $2.57M and bringing the position to 67,393 shares worth $3.23M. The position accounts for ﹤0.01% of the portfolio, ranked #591.
ClearBridge Investments first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $568M in Q2 2025. 1,117 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- ClearBridge Investments held 67,393 shares of Novo Nordisk worth $3.23M as of Q2 2026.
- ClearBridge Investments bought 59,776 Novo Nordisk shares in Q2 2026, an estimated $2.57M.
- Novo Nordisk made up ﹤0.01% of ClearBridge Investments's portfolio in Q2 2026, its #591 holding.
- ClearBridge Investments first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
- ClearBridge Investments's Novo Nordisk position peaked at $568M in Q2 2025.
- 1,117 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.